AU2003269266A1 - Transparent gel composition, for the administration of diclofenac sodium through the skin - Google Patents

Transparent gel composition, for the administration of diclofenac sodium through the skin

Info

Publication number
AU2003269266A1
AU2003269266A1 AU2003269266A AU2003269266A AU2003269266A1 AU 2003269266 A1 AU2003269266 A1 AU 2003269266A1 AU 2003269266 A AU2003269266 A AU 2003269266A AU 2003269266 A AU2003269266 A AU 2003269266A AU 2003269266 A1 AU2003269266 A1 AU 2003269266A1
Authority
AU
Australia
Prior art keywords
administration
skin
gel composition
diclofenac sodium
transparent gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003269266A
Other languages
English (en)
Inventor
Francisco Jose Evaristo Stefano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THALAS GROUP Inc
Original Assignee
THALAS GROUP Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THALAS GROUP Inc filed Critical THALAS GROUP Inc
Publication of AU2003269266A1 publication Critical patent/AU2003269266A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003269266A 2002-10-07 2003-10-07 Transparent gel composition, for the administration of diclofenac sodium through the skin Abandoned AU2003269266A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ARP020103777 2002-10-07
ARP020103777A AR036755A1 (es) 2002-10-07 2002-10-07 Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel
PCT/GB2003/004398 WO2004030665A1 (en) 2002-10-07 2003-10-07 Transparent gel composition, for the administration of diclofenac sodium through the skin

Publications (1)

Publication Number Publication Date
AU2003269266A1 true AU2003269266A1 (en) 2004-04-23

Family

ID=32046253

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003269266A Abandoned AU2003269266A1 (en) 2002-10-07 2003-10-07 Transparent gel composition, for the administration of diclofenac sodium through the skin

Country Status (3)

Country Link
AR (1) AR036755A1 (es)
AU (1) AU2003269266A1 (es)
WO (1) WO2004030665A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
US9050293B2 (en) 2008-07-16 2015-06-09 Juventio, Llc Small molecule solubilization system
EP2416759A2 (en) * 2009-04-08 2012-02-15 Cadila Healthcare Limited Stable pharmaceutical compositions of diclofenac
EA201391043A1 (ru) * 2011-02-17 2014-03-31 Сентисс Фарма Прайвет Лимитед Способ и композиция для замедления сорбции консервантов пластиками
ITMI20121205A1 (it) 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
RU2702898C2 (ru) 2014-09-10 2019-10-14 Гск Консьюмер Хелткер С.А. Композиции диклофенака натрия для местного применения
WO2023180792A1 (en) 2022-03-25 2023-09-28 Glycores 2000 Srl Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof
EP4342449A1 (en) * 2022-09-21 2024-03-27 Haleon CH SARL Hydroalcoholic single phase gel compositions for topical delivery of diclofenac
EP4342450A1 (en) * 2022-09-21 2024-03-27 Haleon CH SARL Hydroalcoholic topical diclofenac formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788794A4 (en) * 1994-08-09 2000-06-28 Tsumura & Co COMPOSITION FOR PREPARATION FOR EXTERNAL USE
EP0879597A4 (en) * 1996-02-07 2001-01-31 Tsumura & Co TRANSPARENT AQUEOUS SOLUTION OF DICLOFENAC SODIUM, MEDICINAL COMPOSITIONS, AND USES

Also Published As

Publication number Publication date
WO2004030665A1 (en) 2004-04-15
AR036755A1 (es) 2004-09-29

Similar Documents

Publication Publication Date Title
AU2003213210A1 (en) Ophthalmic formulation with gum system
EP2295053B8 (en) Novel 2H-chromen-2-one-3-carboxamides for medical uses
AU2003272590A1 (en) Method for ophtalmic administration of medicament
AU2003209285A1 (en) Deazapurine nucleoside analogs and their use as therapeutic agents
AU2003256813A1 (en) Medical tele-robotic system
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
AU2003252299A1 (en) Novel physiologically active substance
AU2003234929A1 (en) Therapeutic agent for diabetes
AU2003250372A1 (en) Pharmaceutical composition
ATE390149T1 (de) Topische emulsionsgel-zubereitung enthaltend diclofenac-natrium
AU2003279911A1 (en) Therapeutic formulations
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2003294318A1 (en) Therapeutic bioconjugates
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003269266A1 (en) Transparent gel composition, for the administration of diclofenac sodium through the skin
AU2003248153A1 (en) Honey-based skin care preparation
AU2003214381A1 (en) Perfume gel composition
AU2003215708A1 (en) Orodispersible pharmaceutical composition comprising perindopril
AU2003264406A1 (en) Drug or cosmetic
AU2003284460A1 (en) Medicinal composition
AU2002238673A1 (en) Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof
AU2003232108A1 (en) 1,1- and 1,2-bisphosphonates as apoliprotein e modulators
AU2003275610A1 (en) Liquid skin protective composition
AU2003281176A1 (en) Medicinal composition for mitigating blood lipid or lowering blood homocystein
AU2003260566A1 (en) Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase